Adjusting for covariates in analysis based on restricted mean survival times

被引:2
作者
Zhong, Yi [1 ]
Zhao, Ou [2 ]
Zhang, Bo [3 ]
Yao, Bin [3 ]
机构
[1] Myovant Sci Inc, Brisbane, CA USA
[2] Loxo Oncol Lilly, 701 Gateway Blvd,Suite 350, San Francisco, CA 94080 USA
[3] Puma Biotechnol Inc, Los Angeles, CA USA
关键词
adjusted Kaplan-Meier estimator; ANCOVA; clinical trial; pseudo-observation; restricted mean survival time; HAZARDS; LIFE;
D O I
10.1002/pst.2151
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We summarize extensions to the analysis of restricted mean survival time (RMST) in the context of time-to-event outcomes. The RMST estimate and its inference are based on the classical Kaplan-Meier curves. When covariate effects are considered, an adjusted RMST (ARMST) estimate can be derived analogously based on adjusted Kaplan-Meier curves. The adjusted Kaplan-Meier Estimator (AKME) was developed to reduce confounding by the method of inverse probability of treatment weighting. We will show how the ARMST method combines the concepts of the RMST and AKME to make inferences. Two regression based methods to adjust for potential covariate effect on the RMST estimates will be compared with the ARMST approach. Simulation studies are performed to compare the different methods with and without covariate adjustments. In addition, we will summarize the extension of RMST and ARMST to the setting with competing risks. The restricted mean time lost (RMTL) and adjusted RMTL (ARMTL) are estimates of interest from cumulative incidence curves. A phase 3 oncology clinical trial example is provided to demonstrate the applications of these methods.
引用
收藏
页码:38 / 54
页数:17
相关论文
共 34 条
  • [1] Decomposition of number of life years lost according to causes of death
    Andersen, P. K.
    [J]. STATISTICS IN MEDICINE, 2013, 32 (30) : 5278 - 5285
  • [2] Pseudo-observations in survival analysis
    Andersen, Per Kragh
    Perme, Maja Pohar
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2010, 19 (01) : 71 - 99
  • [3] Regression analysis of restricted mean survival time based on pseudo-observations
    Andersen, PK
    Hansen, MG
    Klein, JP
    [J]. LIFETIME DATA ANALYSIS, 2004, 10 (04) : 335 - 350
  • [4] [Anonymous], 2018, SAS US GUID RMSTREG
  • [5] [Anonymous], 2019, ADJ COV RAND CLIN TR
  • [6] [Anonymous], 1998, E9 STAT PRINC CLIN T
  • [7] The Mean, Median, and Confidence Intervals of the Kaplan-Meier Survival Estimate-Computations and Applications
    Barker, Chris
    [J]. AMERICAN STATISTICIAN, 2009, 63 (01) : 78 - 80
  • [8] An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use
    Calkins, Keri L.
    Canan, Chelsea E.
    Moore, Richard D.
    Lesko, Catherine R.
    Lau, Bryan
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2018, 18
  • [9] Cole SR, 2015, AM J EPIDEMIOL, V181, P238, DOI 10.1093/aje/kwu122
  • [10] Adjusted restricted mean survival times in observational studies
    Conner, Sarah C.
    Sullivan, Lisa M.
    Benjamin, Emelia J.
    LaValley, Michael P.
    Galea, Sandro
    Trinquart, Ludovic
    [J]. STATISTICS IN MEDICINE, 2019, 38 (20) : 3832 - 3860